Cholecystectomy and the risk of colorectal cancer.

Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol (2009) 1.11

Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study. J Gastroenterol (2013) 1.02

Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening--review of literature. Int J Colorectal Dis (2008) 0.94

Cholecystectomy and the risk of alimentary tract cancers: a systematic review. World J Gastroenterol (2015) 0.91

Performance value of high risk factors in colorectal cancer screening in China. World J Gastroenterol (2009) 0.86

Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis. Surg Endosc (2014) 0.78

Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis (2017) 0.78

Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status. Int J Colorectal Dis (2016) 0.77

Cholecystectomy and the risk of colorectal adenomas. Dig Dis Sci (2007) 0.77

Gallstones: new insights into an old story. F1000Res (2016) 0.75

Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study. Am J Gastroenterol (2016) 0.75

Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies. PLoS One (2017) 0.75

The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study. PLoS One (2017) 0.75

Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol (2003) 2.20

Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99

Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst (2014) 1.50

Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci (2007) 1.50

Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry (2015) 1.43

Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome. Pancreas (2013) 1.41

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology (2012) 1.16

Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med (2010) 1.11

No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05

Do diabetes drugs modify the risk of pancreatic cancer? Gastroenterology (2009) 1.04

Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas (2013) 1.03

Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf (2012) 0.99

Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer (2012) 0.96

Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology (2009) 0.93

Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev (2012) 0.88

Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf (2008) 0.88

Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol (2007) 0.85

Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause (2012) 0.84

Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol (2007) 0.84

Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiol Drug Saf (2009) 0.84

Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf (2014) 0.82

Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf (2015) 0.81

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology (2005) 0.79

Barrett's esophagus in 2008: an update. Keio J Med (2008) 0.79

Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol (2005) 0.79

Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study. Eur J Gastroenterol Hepatol (2015) 0.79

Changes of the HSD17B10 gene expression levels in ulcerative colitis. Inflamm Bowel Dis (2013) 0.78

Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy. J Clin Gastroenterol (2010) 0.77

Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol (2014) 0.76

Diagnosis of pernicious anemia and the risk of pancreatic cancer. Pancreas (2014) 0.75

Factors Predicting Testing and Treatment of Iron Deficiency in a Nationwide Cohort of Anemic UC Patients. Inflamm Bowel Dis (2016) 0.75

Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy. J Clin Gastroenterol (2007) 0.75

A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis. Inflamm Bowel Dis (2017) 0.75

Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas (2017) 0.75

Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors. Clin Nucl Med (2015) 0.75